GRI Bio (GRI) Earnings Date & Reports

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GRI is expected to report earnings to rise 3.30% to -93 cents per share on November 18

Q3'26

Est.

$-0.94

Q2'26

Beat

by $0.44

Q1'26

Missed

by $0.65

Q4'25

Missed

by $13.02

Q3'25

Missed

by $1.04

The last earnings report on August 31 showed earnings per share of -91 cents, beating the estimate of -135 cents. With 19.95K shares outstanding, the current market capitalization sits at 4.20M.

View a ticker or compare two or three

GRI

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for GRI